Vaccines

As new variants and infectious diseases continue to pose challenges worldwide, pharmaceutical companies are intensifying research efforts to develop treatments. For instance, conditions such as COVID-19, respiratory syncytial virus (RSV), and monkeypox. These efforts underscore the industry’s commitment to public health, yet they also introduce volatility in the market as changing sales forecasts impact stock […]

August is National Immunization Awareness Month, an annual observance dedicated to highlighting the crucial role that vaccinations play in maintaining public health. This month, we focus on raising awareness about the importance of vaccines for individuals of all ages and encouraging proactive health management through vaccination. The Importance of Vaccinations Vaccinations are a cornerstone of

Moderna, Inc. (NASDAQ: MRNA) announced today that the U.S. Food and Drug Administration (FDA) has approved mRESVIA® (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine designed to protect adults aged 60 years and older from lower respiratory tract disease caused by RSV infection. This approval, granted under a breakthrough therapy designation, marks the second approved

The CDC has announced several crucial updates to the vaccination schedules for both adults and children for the year 2024. These updates reflect advancements in vaccine development and changes in public health recommendations aimed at preventing a range of infectious diseases. Adult Vaccination Updates Respiratory Syncytial Virus (RSV) Vaccine: RSV is a respiratory virus that